Drug Database
Back to search

Netherlands· NL-b973ee8f01b9

Acenocoumarol Aurobindo 1 mg, tabletten

A acenocoumarol product containing acenocoumarol, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 7 of our 19 countries.

ATC B01AA07

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedAcenocoumarol Aurobindo 1 mg, tablett…ATCB01AA07REGISTER NO.NL-b973ee8f01b9PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about acenocoumarolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Acenocoumarol is registered in 7 of 19 countries.

Countries holding a registration under ATC B01AA07 (acenocoumarol), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search acenocoumarol products by name

Acenocoumarol · ATC B01AA07

7 / 19 countries

  • Belgiumprice
  • Franceprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of acenocoumarol costs, country by country.

Normalised to the WHO defined daily dose (5 mg), the median price runs from $0.21 in France to $0.50 in Switzerland — a ×2.4 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Acenocoumarol · price per daily dose (5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.50
  • FR France$0.21
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
ACENOCOUMAROL
Manufacturer
Aurobindo Pharma B.V.
Country
Netherlands (NL)
ATC code
B01AA07
ATC class
Acenocoumarol
Defined daily dose
5 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    128376

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

209 interactions on record for acenocoumarol.

Graded by severity as the source publishes them — 142 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check acenocoumarol against other medicinesHow interaction checks work

Acenocoumarol · interactions on record

209 records

  • 142 info

Most severe, free to view

    67 more interactions with mechanism and management, from a commercially licensed source.

    Sign in to check
    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Acenocoumarol in 6 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All acenocoumarol products

    Authorised across Europe · EMA

    The same active substance is authorised in 13 EEA countries. Names it is sold under:

    • Austria · Sintrom
    • Belgium · Sintrom
    • Bulgaria · Синтром
    • Spain · Acenocumarol Aurovitas, Sintrom
    • France · Mini-Sintrom, Sintrom
    • United Kingdom (Northern Ireland) · Sinthrome
    • Greece · Sintrom
    • Hungary · Syncumar Mite
    • Italy · Sintrom
    • Luxembourg · Sintrom
    • Poland · Acenocumarol Wzf, Sintrom
    • Portugal · Acenocumarol Generis, Sintrom
    • Romania · Sintrom, Trombostop

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/f0cd667e-4a47-4e82-a3e4-4243c49a8caa
GET /v1/drugs/f0cd667e-4a47-4e82-a3e4-4243c49a8caa?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h128376_smpc.pdf",
  "strength": null,
  "atc_label": "Acenocoumarol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg128376",
  "excipients": [
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL, GEPREGELATINEERD",
    "SILICIUMDIOXIDE (E 551)",
    "TALK (E 553b)"
  ],
  "substances": [
    "ACENOCOUMAROL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h128376.pdf",
  "authorised_at": "2022/10/11",
  "procedure_number": "PT/H/2537/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "128376",
  "additional_monitoring": "N"
}
    API referenceMCP serverPlans

    See everything about acenocoumarol.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console